PUBLICATIONS

Découvrez les dernières publications des partenaires du consortium RHU CONDOR.

Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas

EXPLICYTE – INSTITUT BERGONIE

Journal of Hematology & Oncology, 2024 Oct

New strategies in soft tissue sarcoma treatment

INSTITUT BERGONIE

Journal of Hematology & Oncology, 2024 Sept

Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

INSTITUT BERGONIE –  EXPLICYTE

Mol. Cancer, 2024 Feb

New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting

GUSTAVE ROUSSY

Journal of Hematology & Oncology, Août 2023

Novel biased PAR2 inhibitors with best-in class properties reduce resistance to both targeted therapy and immunotherapy oncology models

DOMAIN THERAPEUTICS

Poster AACR, Avril 2023

B Cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

CENTRE DE RECHERCHE DES CORDELIERS – INSTITUT BERGONIE
Nat Rev Clin Oncol, Juillet 2022

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort

INSTITUT BERGONIE – CENTRE DE RECHERCHE DES CORDELIERS – EXPLICYTE

Nat Rev Clin Oncol, Juin 2022

CONGRES

Découvrez les dernières communications scientifiques des partenaires du consortium RHU CONDOR.

ABONNEZ-VOUS
AUX ACTUALITÉS
DU PROGRAMME CONDOR

+33 (0) 5 56 33 33 33
contact@condorprogram.com
229, Cours de l’Argonne 33000 Bordeaux FRANCE

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...